Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1681/ASN.2015010111PMID 26647423PMCID PMC4978034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNAs in kidney physiology and disease

  2015cited by this paper
• Toll-like receptors: sensing and reacting to diabetic injury in the kidney.

  2014cited by this paper
• Regulation of Inflammatory Phenotype in Macrophages by a Diabetes-Induced Long Noncoding RNA

  2014cited by this paper
• Assessing the survival of exogenous plant microRNA in mice

  2014cited by this paper
• Where are we in diabetic nephropathy: microRNAs and biomarkers?

  2014cited by this paper
• Narcolepsy-cataplexy and schizophrenia in adolescents.

  2014cited by this paper
• Mechanisms and functions of inflammasomes.

  2014cited by this paper
• Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury

  2014cited by this paper
• MicroRNAs in Diabetic Kidney Disease

  2014cited by this paper
• Inflammatory processes in renal fibrosis

  2014cited by this paper
• Molecular mechanisms of diabetic kidney disease.

  2014cited by this paper
• Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy

  2014cited by this paper
• MicroRNA-146a Decreases High Glucose/Thrombin-Induced Endothelial Inflammation by Inhibiting NAPDH Oxidase 4 Expression

  2014cited by this paper
• Diabetic nephropathy—emerging epigenetic mechanisms

  2014cited by this paper
• The Inflammasome

  2013cited by this paper
• Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice

  2013cited by this paper
• Upregulation of microRNA-146a was not accompanied by downregulation of pro-inflammatory markers in diabetic kidney

  2013cited by this paper
• Transforming Growth Factor-β–Induced Cross Talk Between p53 and a MicroRNA in the Pathogenesis of Diabetic Nephropathy

  2013cited by this paper
• The Role of MicroRNA-146a in the Pathogenesis of the Diabetic Wound-Healing Impairment

  2012cited by this paper
• The podocyte as a target for therapies—new and old

  2012cited by this paper
• MicroRNAs, new effectors and regulators of NF‐κB

  2012cited by this paper
• Inflammation in Diabetic Nephropathy

  2012cited by this paper
• Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation.

  2012cited by this paper
• MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy.

  2012cited by this paper
• microRNA regulation of inflammatory responses.

  2012cited by this paper
• Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing

  2012cited by this paper
• Negative regulatory responses to metabolically triggered inflammation impair renal epithelial immunity in diabetes mellitus

  2012cited by this paper
• Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.

  2012cited by this paper
• Role of microRNAs in kidney homeostasis and disease.

  2012cited by this paper
• Macrophages in renal disease.

  2011cited by this paper
• The inflammasome: an integrated view

  2011cited by this paper
• Pathology of human diabetic nephropathy.

  2011cited by this paper
• The inflammasomes in kidney disease.

  2011cited by this paper
• miR-146a–Mediated Extracellular Matrix Protein Production in Chronic Diabetes Complications

  2011cited by this paper
• Transcriptional regulation of macrophage polarization: enabling diversity with identity

  2011cited by this paper
• Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy

  2011cited by this paper
• MicroRNAs in development and disease.

  2011cited by this paper
• Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes

  2011cited by this paper
• A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

  2011cited by this paper
• microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

  2011cited by this paper
• MicroRNAs as mediators and therapeutic targets in chronic kidney disease

  2011cited by this paper
• Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis.

  2011cited by this paper
• miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

  2011cited by this paper
• Macrophages and diabetic nephropathy.

  2010cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• From Fibrosis to Sclerosis Mechanisms of Glomerulosclerosis in Diabetic

  2008cited by this paper
• From Fibrosis to Sclerosis

  2008cited by this paper
• Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes

  2008cited by this paper
• Inflammatory mechanisms of diabetic complications

  2007cited by this paper
• The inflammasome: a danger sensing complex triggering innate immunity.

  2007cited by this paper
• Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification

  2007cited by this paper
• Diabetic nephropathy: a frontier for personalized medicine.

  2006cited by this paper
• NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

  2006cited by this paper
• Inflammation and diabetic nephropathy

  2006cited by this paper
• How does proteinuria cause progressive renal damage?

  2006cited by this paper
• Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease.

  2005cited by this paper
• The inflammasome.

  2005cited by this paper
• Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.

  2004cited by this paper
• High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells.

  2003cited by this paper
• Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.

  2003cited by this paper
• Molecular understanding of hyperglycemia's adverse effects for diabetic complications.

  2002cited by this paper
• Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress

  2002cited by this paper
• Pathogenesis, prevention, and treatment of diabetic nephropathy.

  1998cited by this paper
• Diabetic nephropathy: pathogenesis and treatment.

  1993cited by this paper
• The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control.

  1990cited by this paper

• Capturing the inflammatory landscape within kidney compartments of human diabetic kidney disease: a digital spatial profiling study

  2026cites this paper
• A novel endosome-escaping, macrophage-targeted nanoparticle platform for miR-146a delivery with favorable in vivo biodistribution and biocompatibility

  2026cites this paper
• Multidimensional mechanisms of quercetin in diabetic kidney disease

  2026cites this paper
• Endosome-escaping engineered LNP-miR146a with in vivo biodistribution to mitigate inflammation and foreign body giant cell formation

  2026cites this paper
• Non-coding RNAs as prognostic biomarkers in autoimmune disease.

  2026cites this paper
• Selected miRNAs in Urinary Extracellular Vesicles Show Promise for Early and Specific Diagnostics of Diabetic Kidney Disease

  2025cites this paper
• The role and therapeutic potential of exosome-mediated microRNAs regulatory networks in diabetic kidney disease

  2025cites this paper
• The Linkage Between Inflammation and the Progression of Type 2 Diabetes Mellitus

  2025cites this paper
• MicroRNAs in metabolic syndrome: Mechanisms, diagnosis, and therapy.

  2025cites this paper
• Renal aging and its consequences: navigating the challenges of an aging population

  2025cites this paper
• What a Modern Physician Should Know About microRNAs in the Diagnosis and Treatment of Diabetic Kidney Disease

  2025influential citation
• Immune inflammation and metabolic interactions in the pathogenesis of diabetic nephropathy

  2025cites this paper
• Regulation of pyroptosis in diabetic nephropathy by long non-coding and circular RNAs

  2025cites this paper
• Association of circulatory hsa-miR-146a-5p and hsa-miR-192-5p with impaired fasting glycaemia in HIV infected subjects

  2025cites this paper
• Start small, think big: MicroRNAs in diabetes mellitus and relevant cardiorenal-liver metabolic health spectrum.

  2025cites this paper
• Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases

  2025cites this paper
• Non-Coding RNA in Type 2 Diabetes Cardio–Renal Complications and SGLT2 Inhibitor Response

  2025cites this paper
• Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes

  2025cites this paper
• A comprehensive review of new potential biomarkers in the detection of chronic kidney disease

  2025cites this paper
• The potential role of hydrogen sulfide-autophagy axis in diseases

  2025cites this paper
• Decoding Toll-like receptors: Recent insights and perspectives in innate immunity.

  2024cites this paper
• The Impact of Epigenetics on the Pathophysiology of Type 2 Diabetes and Associated Nephropathic Complications

  2024cites this paper
• Bioinformatics analysis of miRNAs germacrone protection on diabetic nephropathy

  2024cites this paper
• MiRNA Expression in Long-Distance Runners with Musculoskeletal Pain: Implications for Pain Pathophysiology

  2024cites this paper
• Role of hydrogen sulfide-microRNA crosstalk in health and disease.

  2024cites this paper
• microRNAs in kidney diseases: Regulation, therapeutics, and biomarker potential.

  2024cites this paper
• Extracellular Vesicles Derived from Human Liver Stem Cells Counteract Chronic Kidney Disease Development and Cardiac Dysfunction in Remnant Kidney Murine Model: The Possible Involvement of Proteases

  2024cites this paper
• Role of miRNAs in macrophage-mediated kidney injury

  2024cites this paper
• Transcriptome analysis reveals that gga-miR-2954 inhibits the inflammatory response against Eimeria tenella infection.

  2024cites this paper
• Targeting Macrophages: Therapeutic Approaches in Diabetic Kidney Disease

  2024cites this paper
• Ultrasensitive CCL2 Detection in Urine for Diabetic Nephropathy Diagnosis Using a WS2-Based Plasmonic Biosensor.

  2024cites this paper
• Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia.

  2024cites this paper
• Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus

  2023cites this paper
• Circ-0000953 deficiency exacerbates podocyte injury and autophagy disorder by targeting Mir665-3p-Atg4b in diabetic nephropathy

  2023cites this paper
• Plasma miR-19b, miR-34a, and miR-146a expression in patients with type 2 diabetes mellitus and cataract: A pilot study

  2023cites this paper
• Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy

  2023cites this paper
• Clinical association and diagnostic significance of miRNA-29a and miRNA-147b in type 2 diabetes mellitus

  2023cites this paper
• Unravelling blood-based epigenetic mechanisms: the impact of hsa-miR-146a and histone H3 acetylation in lead-induced inflammation among occupational workers

  2023cites this paper
• Capturing the Kidney Transcriptome by Urinary Extracellular Vesicles—From Pre-Analytical Obstacles to Biomarker Research

  2023cites this paper
• Photobiomodulation Therapy Improves Inflammatory Responses by Modifying Stereological Parameters, microRNA-21 and FGF2 Expression.

  2023cites this paper
• Regulatory Roles of MicroRNAs in the Pathogenesis of Metabolic Syndrome

  2023cites this paper
• Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems

  2023cites this paper
• Adipose-derived Stem Cells Improving Inflammatory and Proliferative Responses in an Infected and Ischemic Ulcer Model in Type 1 Diabetic Rats: Insights Into Bacterial Count, Stereological Parameters, microRNA-21, and FGF2 Regulation

  2023cites this paper
• Effectiveness of analog of Humanin in ameliorating streptozotocin-induced diabetic nephropathy in Sprague Dawley rats.

  2023cites this paper
• Proposal of a bioinformatics approach to predict molecular mechanisms involved in inflammatory response: case of ATRA and 1,25(OH)2D in adipocytes

  2023cites this paper
• MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis

  2023cites this paper
• The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy

  2023cites this paper
• Association of MicroRNA-146a with Type 1 and 2 Diabetes and their Related Complications

  2023cites this paper
• Urinary microRNA in Diabetic Kidney Disease: A Literature Review

  2023cites this paper
• MiR-146a encapsulated liposomes reduce vascular inflammatory responses through decrease of ICAM-1 expression, macrophage activation, and foam cell formation.

  2023cites this paper
• The effects of aerobic exercise on blood plasma microRNA level in healthy adults: a systematic review and meta-analysis

  2022cites this paper
• The Role of microRNAs in Inflammation

  2022cites this paper
• Mechanisms and application strategies of miRNA-146a regulating inflammation and fibrosis at molecular and cellular levels (Review)

  2022cites this paper
• Research progress on microRNA in gout

  2022cites this paper
• MiRNA146a and diabetes-related complications: a review.

  2022cites this paper
• Genetic Variants in MIR3142HG Contribute to the Predisposition of IgA Nephropathy in a Chinese Han Population

  2022cites this paper
• Diabetes Induces Permanent Deleterious Effects in the Olfactory Bulb Associated with Increased Tyrosine Hydroxylase Expression and ERK1/2 Phosphorylation.

  2022cites this paper
• Peripheral Blood circRNA Microarray Profiling Identities hsa_circ_0001831 and hsa_circ_0000867 as Two Novel circRNA Biomarkers for Early Type 2 Diabetic Nephropathy

  2022cites this paper
• The Dynamics and Plasticity of Epigenetics in Diabetic Kidney Disease: Therapeutic Applications Vis-à-Vis

  2022cites this paper
• Podocyte-specific deletion of miR-146a increases podocyte injury and diabetic kidney disease

  2022cites this paper
• Systemic single administration of anti‐inflammatory microRNA 146a‐5p loaded in polymeric nanomedicines with active targetability attenuates neointimal hyperplasia by controlling inflammation in injured arteries in a rat model

  2022cites this paper
• miR-181a Improved Renal Inflammation by Targeting TNF-α in a Diabetic Nephropathy Animal Model

  2022cites this paper
• Micro-ribonucleic acid modulation with oxidative stress and inflammation in patients with type 2 diabetes mellitus – a review article

  2022cites this paper
• MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization

  2022cites this paper
• miR-146a promotes M2 macrophage polarization and accelerates diabetic wound healing by inhibiting the TLR4/NF-κB axis.

  2022cites this paper
• Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice

  2022cites this paper
• Profile of urinary exosomal microRNAs and their contribution to diabetic kidney disease through a predictive classification model

  2022cites this paper
• MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS

  2021cites this paper
• MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

  2021cites this paper
• Effect of oral administration of docohexanoic acid on anemia and inflammation in hemodialysis patients: A randomized controlled clinical trial.

  2021cites this paper
• Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points

  2021cites this paper
• NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes

  2021influential citation
• Role of UPP pathway in amelioration of diabetes-associated complications

  2021cites this paper
• Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy.

  2021cites this paper
• MiR-146a mediates TLR-4 signaling pathway to affect myocardial fibrosis in rat constrictive pericarditis model

  2021cites this paper
• Alarming Cargo: The Role of Exosomes in Trauma-Induced Inflammation

  2021cites this paper
• Long noncoding RNAs may impact podocytes and proximal tubule function through modulating miRNAs expression in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus patients

  2021cites this paper
• Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective

  2021influential citation
• Assessing the Association of Mitochondrial Function and Inflammasome Activation in Murine Macrophages Exposed to Select Mitotoxic Tri-Organotin Compounds

  2021cites this paper
• Epigenetics and Inflammation in Diabetic Nephropathy

  2021cites this paper
• Receptor Activator of NF-κB Mediates Podocyte Injury in Diabetic Nephropathy.

  2021cites this paper
• miR-21 and miR-146a: the microRNAs of inflammaging and age-related diseases.

  2021cites this paper
• Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study

  2021cites this paper
• Role of Macrophages and Related Cytokines in Kidney Disease

  2021cites this paper
• Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs.

  2021cites this paper
• Long-Term Decrease of Intraocular Pressure in Rats by Viral Delivery of miR-146a

  2021cites this paper
• Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease

  2021cites this paper
• Nanoparticle mediated RNA delivery for wound healing.

  2021cites this paper
• Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.

  2021cites this paper
• Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis

  2021cites this paper
• MicroRNAs and Their Delivery in Diabetic Fibrosis.

  2021cites this paper
• Identifying Key MicroRNAs Targeted by Narenmandula in a Rodent Nephropathy Model

  2020cites this paper
• miR-146a regulates insulin sensitivity via NPR3

  2020cites this paper
• Gene delivery to tackle diabetic nephropathy

  2020cites this paper
• MicroRNA-199a-3p suppresses high glucose-induced apoptosis and inflammation by regulating the IKKβ/NF-κB signaling pathway in renal tubular epithelial cells

  2020cites this paper
• Emerging role of miRNAs in renal fibrosis

  2020cites this paper
• Harnessing noncoding RNA‐based macrophage polarization: Emerging therapeutic opportunities for fibrosis

  2020cites this paper
• Increased plasma miR-146a levels are associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus.

  2020cites this paper
• The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress

  2020cites this paper
• Effects of quercetin-conjugated with superparamagnetic iron oxide nanoparticles on learning and memory improvement through targeting microRNAs/NF-κB pathway

  2020cites this paper